Category: Medical

  • Final reimbursement rates for 2026 Medicare plans in the US are up 5.06%

    Final reimbursement rates for 2026 Medicare plans in the US are up 5.06%

    The US announced a 5.06% average increase in the government’s final reimbursement rates for 2026 Medicare Advantage health plans run by private insurers, more than double the increase it proposed in January.

    The rate the US government pays to private health insurers to manage healthcare under Medicare for people aged 65 and older or with disabilities, influences the monthly premiums they charge, plan benefits they offer and, ultimately, their profits.

    Higher rates will benefit large US health insurers, including UnitedHealth Group and Humana which have been grappling with steep medical costs related to government-backed Medicare and Medicaid plans.

    Shares of UnitedHealth and Elevance Health rose about 6% in after hours trading, and those of CVS Health added 6.7%. Humana shares jumped 11.5% and Cigna rose 1% in extended trading.

    The final rate indicates “visible evidence of Trump administration’s support for MA program,” said Bernstein analyst Lance Wilkes.

    The Centers for Medicare & Medicaid Services (CMS), which oversees Medicare and Medicaid health insurance programs, had earlier proposed a 2.2% increase in 2026 payments. Last year, the government announced a 0.2% decline in the reimbursement rates for 2025.

    The CMS said the rate change primarily takes into account additional data on the increase in costs for the insurers, including payment data through the fourth quarter of 2024.

    “We’re encouraged that CMS is supportive of this important program,” a spokesperson for CVS said, adding that 88% of its Medicare Advantage members are currently enrolled in CMS’ highly rated plans with 4 stars or more.

    As insurers “review the new policies released in the last two days, they will continue to focus on helping seniors stay healthy, closing gaps in care and supporting those with chronic illness,” said industry lobbying group America’s Health Insurance Plans. Reuters

  • England’s hospitals could remove over 100,000 jobs

    England’s hospitals could remove over 100,000 jobs

    Hospitals in England could axe more than 100,000 jobs as a result of the huge reorganisation and brutal cost-cutting ordered by Wes Streeting and the NHS’s new boss.

    The scale of looming job losses is so large that NHS leaders have urged the Treasury to cover the costs involved, which they say could top £2bn, because they do not have the money.

    Sir Jim Mackey, NHS England’s new chief executive, has told the 215 trusts that provide health care across England to cut the costs of their corporate functions – such as HR, finance and communications – by 50% by the end of the year.

    But the NHS Confederation, which represents trusts, said some trusts believe complying with that edict could force them to shed anywhere between 3% and 11% of their entire workforce.

    If replicated across the 215 trusts, that could lead to job losses ranging from 41,100 to 150,700, given they employ 1.37 million people.

    Matthew Taylor, the NHS Confederation’s chief executive, said trusts were being asked to make such “staggering” savings that they might not be able to help banish the long delays patients faced for treatment.

    He called on the Treasury to create an NHS “national redundancy fund” to foot the bill for job losses because trusts were already too cash-strapped to do so.

    His intervention came as Streeting and Mackey prepared to be questioned by MPs on the Commons health and social care committee on Tuesday about their plans.

    The NHS is bracing itself for an unprecedented loss of jobs after the decision by the health secretary to abolish NHS England and cut a huge number of managers.

    About half of NHS England’s 15,300-strong personnel are set to lose their jobs when it is merged with the Department of Health and Social Care. The DHSC is also expecting some of its 3,300 staff to depart. A further 12,500 jobs could go at the NHS’s 42 integrated care boards – regional oversight bodies that employ 25,000 people between them.

    Taylor said: “Health leaders understand the troubling financial situation facing the country and the need to improve efficiency where they can, as they have already demonstrated by significantly reducing their planned deficit for the year ahead.

    “However, the scale and pace of what has been asked of them to downsize is staggering and leaves them fearful of being able to find the right balance between improving performance and implementing the reforms needed to put the NHS on a sustainable footing.

    “They have told us that unless the Treasury creates a national redundancy fund to cover these job losses, any savings the government hopes to make risks being eroded at best and completely wiped out at worst.”

    He said trusts needed financial stability in order to deliver the government’s forthcoming 10-year health plan.

    Some trust heads are budgeting to spend as much as £12m making staff redundant this year, the Confederation said. But one said they were not planning a redundancy programme “as it will be unaffordable” and will instead use the natural turnover of staff to slim down.

    Sarah Woolnough, the chief executive of the King’s Fund, highlighted research showing that only 14% of people in Britain think the NHS spends its money efficiently.

    Despite that, she said, “the UK spends just 1.9% of its health budget on administration costs – the sixth lowest out of the 19 comparable countries measured”.

    She added: “You need highly skilled and experienced people in key behind-the-scenes roles – including management and administration – in order to enable frontline staff to focus on delivering great care.

    “In the drive to raise NHS efficiency, national politicians need to be aware that cutting cost is not the same as increasing efficiency.”

    Thea Stein, the chief executive of the Nuffield Trust thinktank, echoed Woolnough’s caution about the cost-cutting drive.

    She said: “There is certainly duplication and wasted time in NHS governance, but the government needs to be careful about exactly what gets cut.

    “Corporate staff in NHS trusts include the digital specialists, analysts and recruitment professionals needed to improve NHS efficiency and keep wards staffed.”

    The former NHS trust chief executive added: “Last year’s Darzi review, commissioned by the current government, noted that cuts in the last round of squeezing oversight bodies in 2013 left the NHS short on capable administration and ended up being reversed.”

    In recent days several NHS trusts have outlined plans to shed hundreds of posts each, in a bid to meet what Taylor has called “challenging” efficiency savings targets for 2025-26.

    The trusts, which provide care in Portsmouth and the Isle of Wight, plan to cut 798 whole-time equivalent posts, or about 7% of their combined workforce. They hope to save £39m, almost half their combined £82m savings target, the Health Service Journal reported.

    Similarly, the trust that runs Bristol’s hospitals intends to shrink its workforce by 2%, in a move that could lead to more than 300 job losses.

    NHS England told all 215 trusts to save 5% of their budget for this year through “cost improvement programmes” amid fears the service could overspend its budget by £6.6bn.

    A DHSC spokesperson said: “We will work with the NHS to make the changes needed to get the health service back on its feet, and will focus on delivering for patients and taxpayers while also supporting staff.

    “Our plans to bring NHS England back into the department will eliminate duplication, freeing up hundreds of millions of pounds for frontline care and better treatment for patients.

    “We are investing an extra £26bn in health and care, and have already made progress on our mission to cut waiting lists – delivering an extra 2 million appointments seven months early and cutting the waiting list by 193,000 since July.” The Guardian

  • Trump may repeal the new EtO regulations

    Trump may repeal the new EtO regulations

    Steris says it is holding off on adding sterilization capacity as the Trump Administration reconsiders the EPA’s new ethylene oxide (EtO or EO) regulations.

    The agency issued a final rule last year requiring most commercial sterilizers to monitor and report emissions of EtO, a toxic gas that is the most commonly used sterilant for medical devices. But the Trump Administration said last month that it was reconsidering the regulations along with a host of other Biden-era air pollution rules.

    Speaking today at the Needham Healthcare Conference, the company’s leaders said they have already met most of the new EtO regulations, but could save about $20 million on emissions monitoring if the Trump Administration repeals the regulations.

    Steris provides contract sterilization for medical device manufacturers through its Applied Sterilization Technologies (AST) unit and makes sterile products for hospitals.

    Steris is “reluctant to expand capacity until the EO regulations are sorted out,” Needham & Co. said in a summary of the presentation, which the investment firm hosted for its clients.

    Steris is operating near maximum capacity, which Steris management putting it in the high 90% range, Needham said. Opening a new AST plant costs $40 million to $50 million, they said.

    Steris disclosed costs of up to $48 million last month to settle personal injury lawsuits connected to an EtO plant in Illinois. Today, Steris leaders said AST’s litigation risk appears to be low.

    The FDA, commercial sterilizers and medical device manufacturers have been working on EtO alternatives and emission reductions to lessen the health risks to workers and communities from emissions.

    Steris leaders also said it was too soon to quantify the impact of Trump’s new import taxes. The tariffs affect nearly all countries and have roiled global markets in a manner comparable to the global financial crisis of 2008.

    Steris has manufacturing plants in Mexico and Canada but said it “may not have to pay tariffs on products from these facilities since they are compliant with the USMCA trade agreement,” according to Needham.

    “Importantly, management noted that the European tariffs serve to level the playing field with its European-based competitors,” Needham said. Steris “is evaluating options to combat any tariff impact, including supplier alternatives and pricing. [Steris] also expects minimal impact from China tariffs since it has largely exited the country.” Medical Design & Outsourcing

  • Predictive analytics for healthcare will reach a value of about USD 103.6B

    Predictive analytics for healthcare will reach a value of about USD 103.6B

    The healthcare industry is undergoing a transformative shift driven by advanced technologies, including artificial intelligence (AI), machine learning (ML), and big data analytics. Among the most impactful trends in healthcare is predictive analytics, which uses historical data, statistical algorithms, and machine learning techniques to predict future outcomes and help healthcare providers make more informed decisions. The healthcare predictive analytics market has seen impressive growth over the past few years, and its trajectory is expected to continue expanding, driven by rising demand for cost-efficient, quality-driven healthcare solutions. This research report will explore the healthcare predictive analytics market’s size, growth drivers, challenges, opportunities, and the leading companies poised to dominate the market by 2032.

    Predictive analytics in healthcare refers to the use of data to identify patterns, forecast future events, and improve decision-making processes across the healthcare system. It helps in predicting patient outcomes, reducing hospital readmissions, identifying high-risk patients, and improving operational efficiencies. With its capacity to analyze vast datasets, predictive analytics is empowering healthcare providers to enhance patient care, optimize resource allocation, and lower costs.

    Market size and share
    The healthcare predictive analytics market has witnessed robust growth over the past few years, primarily driven by increasing investments in digital health technologies, a surge in the volume of healthcare data, and the rising need for cost-effective healthcare solutions. As of 2024, the market is valued at USD 14.42 billion. Experts predict that the market will experience a compound annual growth rate (CAGR) of 24.5% between 2025 and 2032. By 2032, the healthcare predictive analytics market is projected to exceed USD 103.6 billion.

    The healthcare predictive analytics market is poised for substantial growth over the next decade, driven by technological advancements, the increasing availability of healthcare data, and the push for improved patient outcomes and cost-efficiency. The integration of AI, machine learning, and big data analytics will continue to shape the future of healthcare, offering immense potential to improve clinical outcomes, reduce operational costs, and enhance overall healthcare delivery. However, challenges such as data privacy concerns and the need for skilled professionals remain critical hurdles. Nonetheless, the market is expected to grow significantly, with major players like IBM, Cerner, and Optum leading the way. SkyQuest Technology

  • A bill to modify charity hospitals’ asset tax breaks is passed by the Senate

    A bill to modify charity hospitals’ asset tax breaks is passed by the Senate

    The Senate has passed a bill to revise property tax exemptions for nonprofit hospitals.

    Senate Majority Caucus Chairman Ben Toews described the bill as “a collaborative effort between the Idaho Association of Counties and the Idaho Hospital Association.” It tightens the general definition of hospital while specifically designating critical access hospitals and rural emergency hospitals for the exemption.

    “This is a great example of the legislative process working well,” said Toews, R-Coeur d’Alene.

    House Bill 130, now amended twice by the Senate, is the result of Ada County’s repeated requests for more control over which hospital properties qualify for the tax exemption.

    Senate Majority Leader Lori Den Hartog, R-Meridian, explained the issue in debate Tuesday.

    “Some of our hospitals now are health systems, so they own and operate – and do – a lot of different things in our community. When the hospital exemption was put into place in this section of code back in the mid to late 90s, we didn’t have what we have today,” Den Hartog said. “In this valley, we have two major health systems. They own and operate a lot of different satellite offices that, again, benefit the community but they’re not what we think of as traditional hospitals.”

    The bill will return to the House for consideration because it has been amended. If they concur with the changes, it moves to the governor’s desk for his signature or veto. Idaho Reports

  • US judicial decisions FDA isn’t able to control tests created in labs

    US judicial decisions FDA isn’t able to control tests created in labs

    The US District Court for the Eastern District of Texas March 31 ruled that the Food and Drug Administration does not have the authority to regulate laboratory-developed tests.

    The FDA last April issued a final rule that would have phased out its general enforcement discretion approach for most lab-developed tests over four years. The phase-out deadlines set in the final rule are no longer in effect.

    The AHA previously expressed concerns about the proposed rule and urged the FDA not to apply the rule to hospital and health system lab-developed tests.

    “This ruling ensures that hospital-based labs are able to continue to develop innovative and high-quality tests that provide physicians with important clinical information to help diagnose and treat patients,” said Jason Kleinman, AHA director of federal relations. “The LDT final rule would have stifled medical innovation and dramatically increased regulatory burden and costs for both hospitals and the federal government.” American Hospital Association

  • India builds a 200-bed field hospital in Mandalay, Myanmar

    India builds a 200-bed field hospital in Mandalay, Myanmar

    As rescue workers work against time to pull out the survivors four days after the shallow 7.7-magnitude earthquake struck Myanmar, killing more than 2,700 people, India has established a 200-bed capacity field hospital comprising 118 personnel and started treating patients in the quake-ravaged country under Operation Brahma.

    The stench of death hung heavy across quake-struck Mandalay, as yet another strong aftershock rattled Myanmar’s second-largest city Mandalay on Tuesday.

    The death toll from the initial quake and a series of aftershocks has climbed to 2,719, according to Myanmar’s military chief. The number of injured stands at 4,521, with more than 400 missing.

    The country, still reeling from the catastrophic 7.7 magnitude earthquake that struck last Friday with an epicentre near Mandalay, continues to be shaken by aftershocks, compounding the misery of residents, who are now taking shelter on the roadsides with their children, fearing further destruction.

    On Tuesday, another aftershock measuring over 5 magnitude rattled Mandalay at 5.31 pm local time, causing at least half a dozen already damaged buildings to collapse.

    Amid the hectic relief and rescue efforts, the Indian Army on Tuesday stated, “As part of the Indian Army’s ongoing humanitarian assistance under Operation Brahma, the field hospital comprising 118 personnel has been successfully established in Mandalay. The hospital was deployed using two Indian Air Force C-17 heavy-lift aircraft and is now fully operational with a 200-bed capacity, offering surgical and inpatient care.”

    The statement added that chief minister of Mandalay Myo Aung visited the facility and reviewed its capabilities on Tuesday morning. “The field hospital is fully prepared and equipped to provide critical medical care to those in need, reinforcing India’s steadfast commitment to humanitarian relief efforts in the region,” it added.

    The Indian diplomats also handed another 30 tonnes of relief aid, food, medical supplies and tents carried by Indian naval ships to Yangon CM U. Soe Thein on Tuesday.

    As part of Operation Brahma, India had earlier intensified its efforts to carry out relief and rescue efforts in Myanmar, including the rescue of thousands of Buddhist monks there. The NDRF team had begun rescue operations on Monday at the U Hla Thein monastery, where around 170 monks are still stuck. About 2,000 Buddhist monks who are safe but with no basic amenities are also being provided relief by Indian rescue teams.

    Prime Minister Narendra Modi had also pointed out that India has always acted as a first responder in the region to any emergency or crisis in the neighbourhood and also referred to the Nepal earthquake a decade ago when Indian relief and rescue teams had worked day and night to bring relief to people there.

    Earlier, five IAF aircraft had landed on Sunday in Myanmar’s largest city Yangon and the capital Naypyitaw, carrying humanitarian assistance and disaster-relief (HADR) material, the 60 Para Field Ambulance team and NDRF personnel. Two giant IAF C-17 Globemaster transport aircraft carrying 60 Para Field Ambulance had landed in Naypyitaw on Sunday. The Indian Army teams then set up their medical services.

    The Myanmar government will also advise Indian teams on deployment sites of relief and rescue teams. The relief material on Monday was also given to the state Mahanayak Committee, which is the second highest-ranking committee in Myanmar.

    Indian teams are being deployed to the Mandalay Palace, Maha Muni Pagoda, MIIT and other such places where substantial damage has occurred. The teams are also providing assistance to members of the Indian community for their stay and food. Deccan Chronicle

  • India will see USD 13.42B in medical tourism

    India will see USD 13.42B in medical tourism

    India’s medical tourism industry is set to witness strong growth, with its market size projected to reach USD 13.42 billion by 2026, according to a report by Grant Thornton.

    The sector’s expansion is driven by India’s cost advantage, growing hospital networks, rising investments, and increasing adoption of technology.

    It said “Medical tourism is projected to reach USD 13.42 billion by 2026, further underlining the sector’s strong growth prospects”.

    One of the major reasons behind India’s emergence as a global healthcare hub is its affordability. The country offers medical treatments at just 20-25 per cent of the cost in developed nations.

    This cost-effectiveness, combined with high-quality healthcare services, attracts patients from across the world, strengthening India’s position in the global medical tourism market.

    The report also mentioned that India’s healthcare industry is not just a growth driver but also a significant contributor to employment.

    The sector has emerged as one of the largest employers in the country, generating numerous job opportunities across hospitals, research centres, and medical technology firms.

    Currently, 60 per cent of hospital beds in the country are concentrated in metro cities, while 70 per cent of India’s population resides in rural areas. This gap presents huge potential for healthcare expansion in Tier 2 and Tier 3 cities, where demand for quality medical services is rising.

    India’s healthcare industry is also experiencing a rapid shift towards digital solutions. AI-powered diagnostics, telemedicine, and other health-tech innovations are transforming patient care.

    The AI-driven healthcare market is expected to grow from USD 14.6 billion in 2023 to USD 102.7 billion by 2028, revolutionizing medical operations and accessibility.

    The expansion of health insurance coverage is further boosting the sector. In FY23, gross direct premium income underwritten by health insurance companies grew to Rs 90,600 crores (USD 10.86 billion). This increasing insurance penetration is making quality healthcare more accessible to the population.

    With cost advantages, infrastructure expansion, mergers, and growing investment in digital health and insurance, India’s medical tourism sector is on a strong growth path.

    As the country continues to enhance healthcare access and efficiency, it is poised to become a global leader in medical tourism in the coming years. NewKerala

  • UP will establish a super specialty hospital in Bareilly

    UP will establish a super specialty hospital in Bareilly

    Uttar Pradesh Chief Minister Yogi Adityanath on Tuesday directed that a proposal be prepared for the construction of a super-speciality hospital in Bareilly, integrating 300 beds with the vacant land of the mental hospital.

    During the divisional review meeting at the Vikas Bhawan auditorium, the CM directed the officials to submit the proposal to the government, emphasising that this initiative would enhance modern medical facilities in the region.

    He also urged public representatives to adopt at least one TB patient each to raise public awareness about the disease. He highlighted the importance of addressing long-pending legal cases, stating that unresolved cases often lead to new crimes. He stressed the need for their swift resolution to maintain law and order.

    Reaffirming Bareilly’s status as a Smart City, Yogi directed that all divisional and district-level offices be housed under one roof for better governance. He directed the officials to draft a proposal for this initiative and make necessary arrangements.

    To improve crime control and traffic management, he called for the effective implementation of the Intelligent Traffic Management System and mandated the verification of e-rickshaws and taxis.

    During the meeting, Divisional Commissioner Saumya Agarwal provided updates on the region’s progress, including completing 25 km of fencing in the Pilibhit Tiger Reserve. She also highlighted that between 2022 and 2024, 12 aspirational development blocks in the division had received recognition from both the central and state Governments.

    Reviewing the resolution of revenue cases, the CM reiterated that cases pending for over a year often become flashpoints for disputes, affecting law and order. He directed the officials to expedite their resolution to ensure justice for the common people.

    He directed that, as Bareilly serves as the commissionerate headquarters, a comprehensive record of all available government land should be prepared and handed over to the development authority. Besides, he directed that chambers and canteens for lawyers should be kept clean, and a conducive environment should be provided for the public. United News of India

  • Rapid malaria evaluations via the WHO detector

    Rapid malaria evaluations via the WHO detector

    Malaria rapid diagnostic tests are under the spotlight at the World Health Organization (WHO), after reports that devices showed positive faint lines for patients with a confirmed malaria infection.

    The WHO said that reports came in last year about positive faint lines. These were predominantly observed in patients with low parasitemia, a term used for the small presence of parasites in the blood. However, some patients with higher parasitemia also generated faint test lines – patients in this group would usually produce strong bands on rapid tests.

    When asked about which manufacturers are impacted by the notice, a WHO spokesperson told Medical Device Network that it is “currently not in a position to provide any more detail on the products”.

    Abbott, Advy Chemical, and Zephyr Biomedicals, amongst others, have tests that meet the WHO’s regulatory standards, as per the agency’s product prequalification database. Exact data on the most widely used brand is difficult to ascertain. In a British Medical Journal (BMJ) study of 85,000 participants across various countries in Africa, Abbott’s SD Bioline Malaria Ag Pf was the most common rapid diagnostic test brand.

    False negative tests usually lead to misdiagnosis, and delays in diagnosis and treatment. The faint test lines, which increase the risk of false negative tests, have led to the issues in recent reports to the WHO.

    “In circumstances where misdiagnosis occurs, the potential for harm, such as death or serious deterioration in health, is increased,” the WHO said in a statement.

    Rapid diagnostic tests have become a key framework for malaria diagnosis. They are an accessible alternative to disease diagnosis by microscopy, where laboratory services might not be available.

    The in vitro diagnostic works by detecting specific antigens produced by malaria parasites in the blood of infected individuals. Depending on the manufacturer, tests can either detect one or multiple species. Their use has led to a sustained increase in testing rates and more accurate tracking of malaria cases.

    According to the medical product alert, incidents were reported in several countries for various products detecting both Plasmodium falciparum and Plasmodium vivax, and products detecting Plasmodium falciparum and pan species.

    Those who use the tests in national control programmes have been recommended to ensure proper transport and storage, up-to-date training, and visual acuity requirements for users. Testing sites should also be contacted to seek feedback on unusual trends, as well as supporting manufacturers.

    As per WHO recommendations, any test line – no matter its faintness – should be recorded as a positive test. However, there have been calls from academia to improve the detection of these bands. For example, some evidence suggests that these bands are sometimes too faded to be seen in poor lighting, a problem in low and middle-income territories.

    There were an estimated 263 million cases of malaria in 2023. The WHO African region carries the highest disease burden, accounting for 94% of cases and 95% of deaths.

    WHO has been grappling with the loss of funding to key malaria programmes in Africa following the suspension of USAID funding. Efforts to fight other infectious diseases such as mpox and tuberculosis have also been impacted.

    “WHO warns that faint lines on rapid tests may cause malaria misdiagnosis” was originally created and published by Medical Device Network, a GlobalData owned brand. GlobalData